Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Goodwill (2023 - 2024)

Perspective Therapeutics' Goodwill history spans 2 years, with the latest figure at $24.1 million for Q3 2024.

  • For Q3 2024, Goodwill fell 11.92% year-over-year to $24.1 million; the TTM value through Sep 2024 reached $24.1 million, down 11.92%, while the annual FY2023 figure was $24.1 million, N/A changed from the prior year.
  • Goodwill for Q3 2024 was $24.1 million at Perspective Therapeutics, roughly flat from $24.1 million in the prior quarter.
  • Across five years, Goodwill topped out at $27.3 million in Q3 2023 and bottomed at $24.1 million in Q4 2023.